Prescient Therapeutics

From WikiMD's Medical Encyclopedia

Revision as of 17:58, 8 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Prescient Therapeutics is a clinical-stage oncology company that specializes in the development of novel drugs that provide treatment options for a variety of cancer types. The company's primary focus is on the development of personalized therapies that target the specific needs of individual patients.

History

Prescient Therapeutics was founded with the aim of developing and commercializing novel, targeted therapies for the treatment of a range of different cancers. The company's approach is based on the understanding that each patient's cancer is unique and requires a personalized treatment strategy.

Research and Development

Prescient Therapeutics' research and development efforts are focused on the discovery and development of novel, targeted therapies for the treatment of cancer. The company's pipeline includes a number of promising drug candidates that are currently in various stages of clinical development.

PTX-100

PTX-100 is a first-in-class compound that blocks the RhoA and RhoC proteins, which are involved in cancer cell growth and survival. PTX-100 has shown promising results in early-stage clinical trials for the treatment of certain types of leukemia and lymphoma.

PTX-200

PTX-200 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor that has shown potential in preclinical and early-stage clinical trials for the treatment of certain types of breast cancer, ovarian cancer, and leukemia.

Clinical Trials

Prescient Therapeutics is currently conducting a number of clinical trials to evaluate the safety and efficacy of its drug candidates. These trials are being conducted in collaboration with leading cancer centers and research institutions around the world.

Future Directions

Prescient Therapeutics continues to explore new avenues for the development of novel, targeted therapies for the treatment of cancer. The company's ongoing research and development efforts are aimed at identifying new drug candidates and advancing its existing pipeline through clinical development.

See Also

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.